- Home
- EVOK vs MULN Comparison
EVOK vs MULN Comparison
Compare EVOK & MULN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- MULN
- Stock Information
- Founded
- EVOK 2007
- MULN 2014
- Country
- EVOK United States
- MULN United States
- Employees
- EVOK N/A
- MULN N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- MULN Auto Manufacturing
- Sector
- EVOK Health Care
- MULN Consumer Discretionary
- Exchange
- EVOK Nasdaq
- MULN Nasdaq
- Market Cap
- EVOK 7.7M
- MULN 6.5M
- IPO Year
- EVOK 2013
- MULN N/A
- Fundamental
- Price
- EVOK $4.43
- MULN $0.07
- Analyst Decision
- EVOK
- MULN
- Analyst Count
- EVOK 0
- MULN 0
- Target Price
- EVOK N/A
- MULN N/A
- AVG Volume (30 Days)
- EVOK 7.2M
- MULN 105.6M
- Earning Date
- EVOK 08-12-2025
- MULN 08-11-2025
- Dividend Yield
- EVOK N/A
- MULN N/A
- EPS Growth
- EVOK N/A
- MULN N/A
- EPS
- EVOK N/A
- MULN N/A
- Revenue
- EVOK $11,594,083.00
- MULN $8,931,612.00
- Revenue This Year
- EVOK $57.82
- MULN N/A
- Revenue Next Year
- EVOK $59.12
- MULN N/A
- P/E Ratio
- EVOK N/A
- MULN N/A
- Revenue Growth
- EVOK 89.89
- MULN 2136.62
- 52 Week Low
- EVOK $1.94
- MULN $0.06
- 52 Week High
- EVOK $12.32
- MULN $83,400,000.00
- Technical
- Relative Strength Index (RSI)
- EVOK 53.72
- MULN 20.12
- Support Level
- EVOK $4.26
- MULN $1.62
- Resistance Level
- EVOK $4.73
- MULN $0.10
- Average True Range (ATR)
- EVOK 0.73
- MULN 0.03
- MACD
- EVOK -0.07
- MULN 26.39
- Stochastic Oscillator
- EVOK 25.95
- MULN 4.61
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About MULN Mullen Automotive Inc.
Mullen Automotive Inc is engaged in manufacturing electric vehicles and building energy solutions. Its portfolio of vehicles is predominantly comprised of commercial trucks and other electric vehicles and includes; Mullen Class 1 Cargo Van, Mullen Three, Bollinger B4 Chassis Cab, and Mullen I-GO. The company's operating segments are Bollinger which derives maximum revenue, and Mullen Commercial.